James F. Oliviero III, CEO, President and Director at Checkpoint Therapeutics, Inc. (CKPT), sold 11,031 shares at $5.00 ($53K) on 2023-03-02, disclosed to the SEC on 2023-03-03.
Open-market sale of $53k CKPT by CEO, President and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.65 | 5,548 | $26K | 48.5% |
| 2 | $5.00 | 5,483 | $27K | 51.5% |
| Total | $4.82 avg | 11,031 | $53K | 100% |
| Filing → |
| CKPT | SELL | 2024-12-20 | $6.1M | — | Filing → |
| CKPT | SELL | 2024-06-28 | $101K | — | Filing → |
| CKPT | SELL | 2024-03-01 | $12K | — | Filing → |